Summary & Overview
CPT 64640: Neurolysis by Chemical, Heat, or Radiofrequency Techniques
CPT code 64640 denotes neurolysis procedures that destroy pain-transmitting nerves using chemical agents, heat, or radiofrequency energy. Nationally, this code captures an important category of interventional pain management services used to achieve longer-term pain control when conservative treatments are inadequate. Use of neurolytic techniques has implications for procedure authorization, facility setting, and clinical documentation to support medical necessity.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication presents national benchmarks and payer coverage context, highlights policy considerations affecting reimbursement and prior authorization, and outlines clinical context for appropriate use of neurolysis techniques. Readers will find concise guidance on coding designation and service classification, comparisons of payer coverage tendencies, and a summary of documentation elements commonly expected by payers.
This resource is intended for billing managers, practice administrators, and clinicians involved in pain management who need a concise, national-level overview of CPT code 64640 and its place within interventional pain care delivery and payer policy.
Billing Code Overview
CPT code 64640 describes neurolysis, the targeted destruction of nerves that transmit pain signals using chemical, heat, or radiofrequency techniques. This procedure is a pain management intervention intended to provide prolonged relief by interrupting pain pathways.
Service type: Interventional pain management procedure
Typical site of service: Hospital outpatient department, ambulatory surgery center, or pain clinic/office procedure suite, depending on facility capabilities and clinical context.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old with chronic lumbar radicular pain refractory to conservative measures including physical therapy, oral analgesics, and epidural steroid injections. The patient reports persistent shooting pain in the right lower extremity corresponding to the S1 dermatome and has had functional impairment for >6 months. Imaging shows degenerative disc disease with foraminal stenosis and correlates with exam and symptom distribution. After multidisciplinary evaluation, the pain management specialist recommends percutaneous radiofrequency neurolysis (thermodegeneration of targeted dorsal root ganglion or medial branch nerves) to disrupt pain transmission.
Clinical workflow: the patient undergoes pre-procedure evaluation including informed consent, medication reconciliation (anticoagulation management), and review of prior imaging. On procedure day in an ambulatory surgery center or hospital outpatient department, monitored anesthesia care or local anesthesia with sedation is provided. Fluoroscopic or CT guidance is used to localize the target nerve(s). Neurolytic technique is performed using radiofrequency ablation or chemical neurolysis per protocol. Post-procedure monitoring occurs in recovery with discharge instructions and follow-up arranged with the pain clinic for outcome assessment and potential additional interventions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | When reporting the physician’s professional service separate from a technical component billed by an institution. |